Skip to main content

ERShares

Filter Media

Recent Media

Anthropic Is the New SpaceX for ETF Issuers

Getting into SpaceX early was spectacularly lucrative. The venture investors who bought years ago at...

READ ARTICLE

SpaceX, Amazon, And What ‘DHQ Stocks’ Can Do For You

In this episode, Mike Larson sits down with Eva Ados, COO and chief investment strategist...

READ ARTICLE

MoneyMasters Podcast 7/23/26: SpaceX, Amazon, & What “DHQ Stocks” can do for YOU

In this special MoneyShow MoneyMasters Podcast episode recorded LIVE at the 2026 Las Vegas Symposium,...

READ ARTICLE

XOVR SpaceX Investment Gained $183M+ in Q2

The ERShares Private-Public Crossover ETF (NASDAQ: XOVR) recorded more than $183 million in unrealized appreciation...

Investors turn up the heat with $1.9bn raised in FinTech this week

Across the 19 deals reported on by FinTech Global this week, there was a grand...

READ ARTICLE

After SpaceX, XOVR ETF Bets $30 Million on Kalshi as Prediction Markets Heat Up

The ERShares Private-Public Crossover ETF (NASDAQ:XOVR) has invested $30 million in Kalshi, making the federally...

READ ARTICLE

XOVR Expands Private Market Strategy with $30 Million Investment in Kalshi

XOVR, the first ETF** to provide access to private equity exposure through a private-public crossover...

READ ARTICLE

XOVR pours $30m into prediction market firm Kalshi

ERShares, adviser to the Nasdaq-listed ERShares Private-Public Crossover ETF (XOVR), has committed $30m to Kalshi,...

READ ARTICLE

XOVR Expands Private Market Strategy with $30 Million Investment in Kalshi

XOVR, the first ETF** to provide access to private equity exposure through a private-public crossover...

READ ARTICLE

Joel Shulman on Bloomberg TV: XOVR, SpaceX Exposure & the Private-Public Crossover ETF

Joel Shulman, Founder & CIO of ERShares, joined Bloomberg TV to discuss SpaceX, Elon Musk,...

Past performance is no guarantee of future results. Please refer to the following disclosures:

The hyperlinks and website references on this page may forward you to third-party websites. All descriptions of, reference to, or links to other products, publications, or services do not constitute an endorsement by ERShares unless expressly stated by ERShares. The information, products, and sites accessible through this page have not necessarily been reviewed by ERShares and are provided or maintained by the third parties over whom ERShares does not exercise control. ERShares does not claim any responsibility for the content, accuracy, or quality of the information, products, and/or services provided by or advertised on these third-party websites. ERShares reserves the right to terminate any hyperlink at any time without notice.

Get access to fund materials

Stay up-to-date with market trends

To invest/know more about our products